- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03692728
Increased Risk of ADHD Among Children With Bilateral Congenital Cataracts
October 2, 2018 updated by: Haotian Lin, Sun Yat-sen University
Increased Risk of Attention Deficit Hyperactivity Disorder Among Children With Bilateral Congenital Cataracts
In this study, the investigators conducted a cross-sectional, face-to-face investigation to evaluate the behavioral and psychological disorders and the risk of ADHD among children with bilateral congenital cataracts using the Conners'Parent Rating Scale (CPRS) questionnaire, an assessment tool for screening ADHD that obtains parental reports of childhood behavioral problems in research and clinical settings.15-17
Age-matched children with normal vision and the Chinese urban norm were used as controls.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
262
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Zhognshan Ophthalmic Center, Sun Yat-sen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 8 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
hospital-based
Description
Inclusion Criteria:
- CC children and NV children aged 3-8 years presenting to the Zhognshan Ophthalmic Center between July and December 2016.
Exclusion Criteria:
- Patients complicated with systemic manifestations, such as Lowe syndrome, Marfan syndrome, and Down syndrome, were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CC children
CC children were registered members of the Childhood Cataract Program of the Chinese Ministry of Health (CCPMOH).
All of them were diagnosed with CC by two experienced pediatric ophthalmologists based on a comprehensive evaluation of the onset age (within one year after birth), morphological features of lens opacity, family history, and detailed medical records.
|
Differences in age and sex between the CC and NV groups were compared using the independent samples t test and Chi-square test, respectively.
Comparisons of abnormal rates between the CC and NV groups were performed using the Chi-square test.
Scores on all subscales recorded for the CC group were compared with those of the NV group and the Chinese urban norm using the independent samples t test and one-sample t test, respectively.
|
|
NV children
NV children were recruited from the Optometry Department of the ZOC as the control group.
NV was defined as BCVA ≥0.3 (log MAR) in children between 3-5 years old or BCVA ≥0.15 (log MAR) in children older than 5 years.
Children with strabismus and high refractive error (myopia or hyperopia: >6.0 Diopters; astigmatism: >3.0 Diopters) were excluded from NV group.
|
Differences in age and sex between the CC and NV groups were compared using the independent samples t test and Chi-square test, respectively.
Comparisons of abnormal rates between the CC and NV groups were performed using the Chi-square test.
Scores on all subscales recorded for the CC group were compared with those of the NV group and the Chinese urban norm using the independent samples t test and one-sample t test, respectively.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk of ADHD
Time Frame: 2016.7-12
|
The Conners' Parent Rating Scale 48 (CPRS-48) contains 5 evaluating subscales, including the conduct problems, learning problems, psychosomatic, impulsiveness/hyperactivity, and anxiety subscales.
A total of 48 items are included in the questionnaire, and each item is scored from 0 to 3 (0 represents the best, 3 represents the worst).
The final scores of the 5 subscales are defined as the mean scores of the corresponding items: conduct problems (2+8+14+19+20+21+22+23+27+33+34+39)/12; learning problems (10+25+31+37)/4; psychosomatic (32+41+43+44+48)/5; impulsiveness/hyperactivity (4+5+11+13)/4; anxiety (12+16+24+47)/4; and the hyperactivity index (4+7+11+13+14+25+31+33+37+38)/10.
Final scores and the five subscales of the CPRS-48 between two groups were compared.
|
2016.7-12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2016
Primary Completion (ACTUAL)
December 1, 2016
Study Completion (ACTUAL)
December 1, 2016
Study Registration Dates
First Submitted
September 29, 2018
First Submitted That Met QC Criteria
October 1, 2018
First Posted (ACTUAL)
October 2, 2018
Study Record Updates
Last Update Posted (ACTUAL)
October 4, 2018
Last Update Submitted That Met QC Criteria
October 2, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCPMOH2018- China9
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Cataract
-
Cambridge University Hospitals NHS Foundation TrustCompletedChildhood CataractUnited Kingdom
-
Sun Yat-sen UniversityCompleted
-
Colvard Kandavel Eye CenterEnrolling by invitationCataract | Cataract Bilateral | Cataract Surgery | Cataract (Post-operative Cataract Surgery Follow-up)United States
-
Matthew RauenNot yet recruitingNuclear Cataract | Cataract Surgery Anesthesia | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Züleyha SönmezAtaturk UniversityActive, not recruitingCataract Surgery | Cataract Patients | Cataract After SurgeryTurkey (Türkiye)
-
Stanford UniversityEnrolling by invitationIntraocular Lens | Cataract Extraction | Cataract Surgery | Eye Disorders | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Seva Canada SocietyPragyaan Sustainable Health Outcomes Foundation; Sadgura Netra ChikitsalayaNot yet recruitingCataract (Post-operative Cataract Surgery Follow-up)
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Nicole Fram M.D.RecruitingCataract Bilateral | Nuclear Sclerosis of the Lens | Phacoemulsification Cataract SurgeryUnited States
Clinical Trials on Psychological and Behavioral Problems
-
Centre Hospitalier Universitaire, AmiensSociété de Dermatologie Française; Institut de Recherches Internationales ServierCompleted
-
Nigde Omer Halisdemir UniversityThe Scientific and Technological Research Council of TurkeyCompletedHealthy Young AdultsTurkey (Türkiye)
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Sarcoma | Stage III Uterine Sarcoma | Ovarian Stromal Cancer | Stage I Uterine Sarcoma | Stage II Uterine Sarcoma | Stage IIA Fallopian Tube Cancer | Stage IIB Fallopian Tube Cancer | Stage IIC Fallopian Tube Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIB Fallopian Tube Cancer and other conditionsUnited States
-
Oslo University HospitalUniversity of Bergen; Haukeland University Hospital; University Hospital, Akershus and other collaboratorsCompleted
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, FranceRecruiting
-
IRCCS Eugenio MedeaBasque Center on Cognition, Brain and Language (BCBL)RecruitingLanguage Development Disorders | Infant Development | Language Development | Infant Developmental AssessmentItaly
-
Henry Ford Health SystemRecruitingDepression | Anterior Cruciate Ligament Injuries | Mental Health IssueUnited States
-
University Hospital, MontpellierIdorsia Pharmaceuticals Ltd.RecruitingSleep | Alzheimer Disease | Insomnia DisorderFrance
-
Ohio State UniversityRecruitingNeurodevelopmental Disorders | Autism Spectrum Disorder | Pre-Term | Motor Delay | Cerebral Palsy InfantileUnited States
-
Alexandria UniversityActive, not recruiting